Enhancing quality of life as a goal for anticancer therapeutics.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 27334258.
- Also identified by DOI 10.1126/scitranslmed.aag0382.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Translational cancer research requires a quality-of-life-driven agenda.
Medical subject headings
- Neoplasms
- Quality of Life
- Translational Research, Biomedical